T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
+$1.87B |
| 2 |
T-Mobile US
TMUS
|
+$1.53B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.43B |
| 4 |
Apple
AAPL
|
+$1.28B |
| 5 |
PepsiCo
PEP
|
+$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.16B |
| 2 |
Amazon
AMZN
|
+$3.02B |
| 3 |
GE Aerospace
GE
|
+$2.2B |
| 4 |
Goldman Sachs
GS
|
+$1.76B |
| 5 |
Salesforce
CRM
|
+$1.43B |
Sector Composition
| 1 | Technology | 30.27% |
| 2 | Healthcare | 17.75% |
| 3 | Financials | 11.3% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Communication Services | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Neurocrine Biosciences
NBIX
$14.3B
| $141M | 0.02% |
1,394,149
-31,141
| -2% | -$3.15M |
|
452
Packaging Corp of America
PKG
$19.4B
| $141M | 0.02% |
1,013,738
-862,717
| -46% | -$120M |
|
453
Ionis Pharmaceuticals
IONS
$10.3B
| $141M | 0.02% |
3,934,951
-357,480
| -8% | -$12.8M |
|
454
MGM Resorts International
MGM
$9.8B
| $140M | 0.02% |
3,153,620
-364,858
| -10% | -$16.2M |
|
455
Dollar Tree
DLTR
$20.3B
| $140M | 0.02% |
972,003
-15,399
| -2% | -$2.21M |
|
|
EDR
456
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $139M | 0.02% |
5,814,416
+978,196
| +20% | +$23.4M |
|
457
Etsy
ETSY
$5.55B
| $139M | 0.02% |
1,245,984
+462,507
| +59% | +$51.5M |
|
458
Kymera Therapeutics
KYMR
$3.11B
| $138M | 0.02% |
4,666,681
+287,522
| +7% | +$8.52M |
|
|
AIV
459
Aimco
AIV
$1.1B
| $138M | 0.02% |
17,952,941
+513,565
| +3% | +$3.95M |
|
460
Charter Communications
CHTR
$36B
| $138M | 0.02% |
386,036
+52,873
| +16% | +$18.9M |
|
461
Canadian National Railway
CNI
$59.5B
| $138M | 0.02% |
+1,165,940
| New | +$138M |
|
462
Cboe Global Markets
CBOE
$24.5B
| $136M | 0.02% |
1,015,184
+618,644
| +156% | +$83M |
|
463
IAC Inc
IAC
$2.92B
| $136M | 0.02% |
3,210,155
-112,869
| -3% | -$4.78M |
|
464
Main Street Capital
MAIN
$5.9B
| $135M | 0.02% |
3,425,606
+72,880
| +2% | +$2.88M |
|
465
10x Genomics
TXG
$1.68B
| $135M | 0.02% |
2,413,960
+401,785
| +20% | +$22.4M |
|
466
Bath & Body Works
BBWI
$5.87B
| $134M | 0.02% |
3,675,407
+14,850
| +0.4% | +$543K |
|
467
Incyte
INCY
$16.9B
| $131M | 0.02% |
1,818,347
-101,942
| -5% | -$7.37M |
|
468
Capital One
COF
$141B
| $127M | 0.02% |
1,322,356
-19,442
| -1% | -$1.87M |
|
469
Enphase Energy
ENPH
$4.96B
| $127M | 0.02% |
604,610
-62,693
| -9% | -$13.2M |
|
470
HDFC Bank
HDB
$181B
| $126M | 0.02% |
1,892,630
-629,184
| -25% | -$41.9M |
|
471
BioMarin Pharmaceuticals
BMRN
$10.7B
| $126M | 0.02% |
1,294,047
+366,211
| +39% | +$35.6M |
|
472
Ares Management
ARES
$38.7B
| $125M | 0.02% |
1,502,659
+922,675
| +159% | +$77M |
|
473
Raymond James Financial
RJF
$33B
| $125M | 0.02% |
1,339,345
+513,985
| +62% | +$47.9M |
|
474
XP
XP
$9.76B
| $124M | 0.02% |
10,451,090
-4,215,006
| -29% | -$50M |
|
475
EastGroup Properties
EGP
$8.91B
| $123M | 0.02% |
746,609
+27,223
| +4% | +$4.5M |
|